Complete In-home Therapy Llc in Ashford, CT - Clinic/Center

Complete In-home Therapy Llc is a primary clinic (Clinic/center - Multi-specialty) in Ashford, Connecticut. The current practice location for Complete In-home Therapy Llc is 430 Mansfield Rd, Ashford, Connecticut. For appointments, you can reach them via phone at (860) 573-4923. The mailing address for Complete In-home Therapy Llc is 430 Mansfield Rd, Ashford, Connecticut and phone number is (860) 573-4923.

Complete In-home Therapy Llc is licensed to practice in Connecticut (license number LLC 1084683) and its NPI number is 1750635967. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (860) 573-4923.

Contact Information

	Complete In-home Therapy Llc
	430 Mansfield Rd Ashford CT 06278-1416
	(860) 573-4923
	Not Available

Primary Care Clinic Profile

Full Name	Complete In-home Therapy Llc
Speciality	Clinic/center - Multi-specialty
Location	430 Mansfield Rd, Ashford, Connecticut
Authorized Official Name and Position	Keith Alexander Lyons (MEMBER)
Authorized Official Contact	8605734923
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Complete In-home Therapy Llc 430 Mansfield Rd Ashford CT 06278-1416 Ph: (860) 573-4923	Complete In-home Therapy Llc 430 Mansfield Rd Ashford CT 06278-1416 Ph: (860) 573-4923

NPI Details:

NPI Number	1750635967
Provider Enumeration Date	11/09/2012
Last Update Date	04/22/2013

Medical Identifiers

Medical identifiers for Complete In-home Therapy Llc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1750635967	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261QM1300X	Clinic/center - Multi-specialty	LLC 1084683 (Connecticut)	Primary

News Archive

Breath Analysis: How Could it Improve Healthcare and Diagnosis?

In this interview, News-Medical talks to Santi Dominguez (SD) and Michael Graz (MG), CEOs at

Newcastle University scientists document action spectrum of ultraviolet damage in skin cells

Scientists at Newcastle University have documented for the first time the DNA damage which can occur to skin across the full range of ultraviolet radiation from the sun providing an invaluable tool for sun-protection and the manufacturers of sunscreen.

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's HE4 Test in an algorithm called ROMA (HE4 EIA + ARCHITECT CA 125 II) to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

Chagas disease confirmed as 'silent killer' in first large-scale US survey

A study of almost 5,000 Latin American-born residents of Los Angeles County found that 1.24% tested positive for Chagas disease, a parasitic infection that can cause life-threatening heart damage if not treated early. Chagas disease is one of the leading causes of heart failure in Latin America.

Complete In-home Therapy Llc - Primary Care in Ashford, CT